Structures by: Johnston B. F.
Total: 45
Olanzapine propan-1-ol
C17H20N4S,C3H8O
CrystEngComm (2018) 20, 28 3947
a=10.217(3)Å b=13.069(4)Å c=14.918(5)Å
α=90.00° β=95.342(7)° γ=90.00°
1-(4-Chlorobenzoyl)-5-methoxy-2-methyl-1H-indole-3-acetic acid 1,2-benzisothiazol-3(2H)-one 1,1-dioxide
C19H16ClNO4,C7H5NO3S
CrystEngComm (2019) 21, 30 4465
a=7.1314(2)Å b=10.4809(2)Å c=16.7109(4)Å
α=80.5779(12)° β=86.4941(12)° γ=79.2821(12)°
?1-(4-Chlorobenzoyl)-5-methoxy-2-methyl-1H-indole-3-acetic acid 1,2-benzisothiazol-3(2H)-one 1,1-dioxide
C19H16ClNO4,C7H5NO3S
CrystEngComm (2019) 21, 30 4465
a=6.7888(3)Å b=9.6045(11)Å c=16.3703(16)Å
α=77.764(8)° β=84.858(6)° γ=81.297(8)°
1-(4-Chlorobenzoyl)-5-methoxy-2-methyl-1H-indole-3-acetic acid 1,2-benzisothiazol-3(2H)-one 1,1-dioxide
C19H16ClNO4,C7H5NO3S
CrystEngComm (2019) 21, 30 4465
a=6.7561(3)Å b=9.5308(11)Å c=16.3385(16)Å
α=77.508(8)° β=84.710(6)° γ=81.556(8)°
1-(4-Chlorobenzoyl)-5-methoxy-2-methyl-1H-indole-3-acetic acid 1,2-benzisothiazol-3(2H)-one 1,1-dioxide
C19H16ClNO4,C7H5NO3S
CrystEngComm (2019) 21, 30 4465
a=6.7109(4)Å b=9.4367(12)Å c=16.2988(17)Å
α=77.132(9)° β=84.534(7)° γ=81.962(9)°
1-(4-Chlorobenzoyl)-5-methoxy-2-methyl-1H-indole-3-acetic acid 1,2-benzisothiazol-3(2H)-one 1,1-dioxide
C19H16ClNO4,C7H5NO3S
CrystEngComm (2019) 21, 30 4465
a=6.9301(4)Å b=9.9420(7)Å c=16.514(3)Å
α=79.013(11)° β=85.441(10)° γ=80.339(5)°
1-(4-Chlorobenzoyl)-5-methoxy-2-methyl-1H-indole-3-acetic acid 1,2-benzisothiazol-3(2H)-one 1,1-dioxide
C19H16ClNO4,C7H5NO3S
CrystEngComm (2019) 21, 30 4465
a=7.0133(6)Å b=10.155(2)Å c=16.607(3)Å
α=79.683(14)° β=85.829(11)° γ=79.844(14)°
1-(4-Chlorobenzoyl)-5-methoxy-2-methyl-1H-indole-3-acetic acid 1,2-benzisothiazol-3(2H)-one 1,1-dioxide
C19H16ClNO4,C7H5NO3S
CrystEngComm (2019) 21, 30 4465
a=6.6623(3)Å b=9.3453(11)Å c=16.2637(15)Å
α=76.764(8)° β=84.331(6)° γ=82.375(8)°
(5H-dibenz(b,f)azepine-5-carboxamide)N,N-dimethyl acetamide solvate
C19H21N3O2
CrystEngComm (2008) 10, 1 23
a=7.5046(7)Å b=19.506(2)Å c=11.7808(13)Å
α=90.00° β=96.597(8)° γ=90.00°
(5H-dibenz(b,f)azepine-5-carboxamide)nitromethane solvate
C16H15N3O3
CrystEngComm (2008) 10, 1 23
a=10.9242(11)Å b=5.1617(5)Å c=26.309(3)Å
α=90.00° β=100.104(2)° γ=90.00°
(5H-dibenz(b,f)azepine-5-carboxamide) N-methylpyrrolidine solvate
C20H21N3O2
CrystEngComm (2008) 10, 1 23
a=7.5448(4)Å b=19.5119(10)Å c=11.8783(6)Å
α=90.00° β=98.013(3)° γ=90.00°
1,3,5-Trisilylbenzene
C6H12Si3
Dalton transactions (Cambridge, England : 2003) (2005) 13 2292-2299
a=11.3393(6)Å b=11.3393(6)Å c=16.3909(14)Å
α=90.00° β=90.00° γ=90.00°
Loxapine succinate monohydrate
2(C18H19ClN3O),C4H4O42,C4H6O4,2(H2O)
Acta Crystallographica Section C (2013) 69, 11 1273-1278
a=9.4171(6)Å b=9.7604(7)Å c=13.7949(9)Å
α=74.708(2)° β=86.102(2)° γ=65.518(2)°
Loxapine succinate
C18H19ClN3O,C4H5O4
Acta Crystallographica Section C (2013) 69, 11 1273-1278
a=36.1824(5)Å b=7.08622(14)Å c=18.7690(2)Å
α=90° β=113.8402(10)° γ=90°
Nicotinamide 2,2,2-trifluoroethanol(2/1)
2(C6H6N2O),C2H3F3O
Acta Crystallographica Section E (2009) 65, 4 o727-o728
a=5.0472(3)Å b=11.2930(7)Å c=15.0877(10)Å
α=107.002(3)° β=96.636(3)° γ=95.753(3)°
C4H3ClN2O
C4H3ClN2O
The Journal of organic chemistry (2018) 83, 3 1510-1517
a=4.7980(8)Å b=5.6534(11)Å c=19.038(3)Å
α=90° β=90° γ=90°
Olanzapine
C17H20N4S1
Crystal Growth & Design (2013) 13, 4 1602
a=10.3411(13)Å b=14.521(2)Å c=10.5314(14)Å
α=90.00° β=100.291(4)° γ=90.00°
Olanzapine
C17H20N4S1
Crystal Growth & Design (2013) 13, 4 1602
a=9.8544(14)Å b=16.314(2)Å c=9.9754(12)Å
α=90.00° β=98.304(8)° γ=90.00°
Olanzapine 2-butoxyethanol
C17H20N4S1,(C6H14O2)
Crystal Growth & Design (2013) 13, 4 1602
a=10.4420(10)Å b=17.7328(15)Å c=15.5165(13)Å
α=90.00° β=126.279(5)° γ=90.00°
Olanzapine 2,2,2-trifluoroethanol
C17H20N4S1,2(C2F3O1H3)
Crystal Growth & Design (2013) 13, 4 1602
a=12.7244(9)Å b=11.7538(8)Å c=16.0067(11)Å
α=90.00° β=94.782(2)° γ=90.00°
Olanzapine acetic acid
C17H20N4S1(C2O2H4)
Crystal Growth & Design (2013) 13, 4 1602
a=10.0427(11)Å b=12.7430(13)Å c=14.3886(15)Å
α=90.00° β=92.436(4)° γ=90.00°
Olanzapine ethyleneglycol
C17H20N4S1,(C2H6O2)
Crystal Growth & Design (2013) 13, 4 1602
a=9.8393(16)Å b=13.278(2)Å c=14.588(2)Å
α=90.00° β=96.328(7)° γ=90.00°
Olanzapine ethanol
C17H20N4S1,C2H6O1
Crystal Growth & Design (2013) 13, 4 1602
a=10.3489(18)Å b=13.003(2)Å c=13.870(2)Å
α=90.00° β=92.496(6)° γ=90.00°
Olanzapine TBMe hydrate
C17H20N4S1,(C5H12O1),2(H2O1)
Crystal Growth & Design (2013) 13, 4 1602
a=14.2070(1)Å b=12.2211(9)Å c=14.550(1)Å
α=90.00° β=109.239(3)° γ=90.00°
Olanzapine t-butanol hydrate
2(C17H20N4S1),2(C4H10O1),5(H2O1)
Crystal Growth & Design (2013) 13, 4 1602
a=14.2491(9)Å b=12.3838(8)Å c=27.1418(17)Å
α=90.00° β=99.052(2)° γ=90.00°
Olanzapine 3-methyl 1-butanol hydrate
2(C17H20N4S1),2(C5H12O1),2(H2O)
Crystal Growth & Design (2013) 13, 4 1602
a=12.3420(17)Å b=13.3559(18)Å c=14.630(2)Å
α=105.883(6)° β=90.290(6)° γ=92.005(6)°
Olanzapine N,N dimethylforamide hydrate
2(C17H20N4S),(C3H7NO1)2(H2O1)
Crystal Growth & Design (2013) 13, 4 1602
a=14.9885(9)Å b=12.7558(7)Å c=19.8567(12)Å
α=90.00° β=93.348(2)° γ=90.00°
Olanzapine 1.4-butanediol hydrate
2(C17H20N4S1),(C4O2H10),2(H2O1)
Crystal Growth & Design (2013) 13, 4 1602
a=12.2637(11)Å b=14.1146(10)Å c=14.1783(12)Å
α=63.985(3)° β=65.649(4)° γ=65.437(4)°
Olanzapine-2-pentanol hydrate
C17H20N4S1,C5H12O1,H2O
Crystal Growth & Design (2013) 13, 4 1602
a=13.4466(10)Å b=12.3833(9)Å c=14.5522(9)Å
α=90.00° β=104.839(2)° γ=90.00°
Olanzapine N,N,N-triethylamine hydrate
(C17H20N4S),0.5(C6H15N)2(H2O)
Crystal Growth & Design (2013) 13, 4 1602
a=14.8170(10)Å b=12.6230(10)Å c=14.4610(10)Å
α=90.00° β=113.36(2)° γ=90.00°
Olanzapine pyridine hydrate
2(C17H20N4S1),(C5H5N)2(H2O)
Crystal Growth & Design (2013) 13, 4 1602
a=14.8824(7)Å b=12.7289(7)Å c=20.3218(11)Å
α=90.00° β=93.465(2)° γ=90.00°
Olanzapine 1-butanol hydrate
C17H20N4S1,0.5(C4H10O1),H2O1
Crystal Growth & Design (2013) 13, 4 1602
a=24.575(6)Å b=12.429(3)Å c=15.006(3)Å
α=90.00° β=125.255(7)° γ=90.00°
Olanzapine nitromethane hydrate
C17H20N4S1,0.5(CH3NO2),(H2O)
Crystal Growth & Design (2013) 13, 4 1602
a=24.352(3)Å b=12.3706(13)Å c=15.0182(18)Å
α=90.00° β=125.531(5)° γ=90.00°
Olanzapine 1,2-dimethoxyethane hydrate
(C17H20N4s1),0.5(C4H10O2),(H2O)
Crystal Growth & Design (2013) 13, 4 1602
a=24.4675(13)Å b=12.2298(8)Å c=15.1073(8)Å
α=90.00° β=125.675(2)° γ=90.00°
Olanzapine methanol
C17H20N4S1(C1H4O1)
Crystal Growth & Design (2013) 13, 4 1602
a=10.1493(9)Å b=12.2895(10)Å c=14.0944(13)Å
α=90.00° β=91.905(5)° γ=90.00°
Olanzapine dihydrate
C17H20N4S1,2(H2O1)
Crystal Growth & Design (2013) 13, 4 1602
a=9.846(2)Å b=12.672(3)Å c=14.384(3)Å
α=90.00° β=92.724(9)° γ=90.00°
Olanzapine dichloromethane
2(C17H20N4S1),1(CH2Cl2)
Crystal Growth & Design (2013) 13, 4 1602
a=9.6671(15)Å b=11.5070(17)Å c=16.697(2)Å
α=103.991(6)° β=96.989(6)° γ=99.825(6)°
Olanzapine 1,4-dioxan hydrate
C17H20N4S,0.5(C4H8O2),(H2O1)
Crystal Growth & Design (2013) 13, 4 1602
a=24.447(3)Å b=12.5660(16)Å c=14.9591(19)Å
α=90.00° β=125.421(5)° γ=90.00°
Olanzapine acetonitrile hydrate
(C17H20N4S1),(C2H3N1),(H2O)
Crystal Growth & Design (2013) 13, 4 1602
a=24.381(2)Å b=12.3856(9)Å c=15.0565(14)Å
α=90.00° β=125.321(7)° γ=90.00°
Olanzpaine tetrahydrofuran hydrate
C17H20N4S,0.5(C4H8O),(H2O)
Crystal Growth & Design (2013) 13, 4 1602
a=24.2355(10)Å b=12.5913(5)Å c=15.0767(6)Å
α=90.00° β=124.9990(10)° γ=90.00°
Olanzapine acetone hydrate
C17H20N4S1,0.5(C3O1H6),(H2O1)
Crystal Growth & Design (2013) 13, 4 1602
a=24.226(2)Å b=12.5269(12)Å c=15.0737(15)Å
α=90.00° β=124.976(4)° γ=90.00°
Olanzapine methylacetate hydrate
C17H20N4S1,0.5(C3H6O2),H2O1
Crystal Growth & Design (2013) 13, 4 1602
a=24.899(4)Å b=12.5316(19)Å c=15.243(2)Å
α=90.00° β=126.990(5)° γ=90.00°
Olanzapine 1,2 propanediol hydrate
C17H20N4S1,(C3H8O2),(H2O)
Crystal Growth & Design (2013) 13, 4 1602
a=24.704(2)Å b=12.1883(10)Å c=15.1242(12)Å
α=90.00° β=125.206(3)° γ=90.00°
Olanzapine 1-propanol hydrate
C17H20N4S1,0.5(C3H8O1),(H2O1)
Crystal Growth & Design (2013) 13, 4 1602
a=24.4748(13)Å b=12.3515(6)Å c=15.1109(8)Å
α=90.00° β=125.6490(10)° γ=90.00°
Olanzapine higher hydrate
C17H20N4S1,2.5(H2O1)
Crystal Growth & Design (2013) 13, 4 1602
a=24.940(6)Å b=12.156(3)Å c=14.867(3)Å
α=90.00° β=124.928(6)° γ=90.00°